The global insomnia treatment market is projected to grow significantly during the forecast period. Insomnia is a sleep disorder that has been prevalent across the globe. Insomnia is also referred to as sleeplessness that disturbs the sleep cycle and creates distress in patients. Patients with this insomnia face difficulty in falling asleep or staying asleep for a long time. Insomnia leads to low energy, irritability, daytime sleepiness, and a depressed mood in patients that may affect concentration and ability to focus.
Get Free Sample link @ https://www.omrglobal.com/request-sample/insomnia-treatment-market
Insomnia can occur due to mental stress, chronic pain, restless leg syndrome, menopause, and others. The increasing prevalence of insomnia primarily drives the growth of the market during the forecast. Some of the factors that lead to insomnia include excessive stress, eating too much late in the evening, and sleep apnea disorders. Primarily, insomnia can be treated by improving sleep hygiene and lifestyle. Sleep lifestyle may get better with consistent bedtime, a quiet and darkroom, exposure to sunlight, and regular exercise.
A full report of Global Insomnia Treatment Market available @ https://www.omrglobal.com/industry-reports/insomnia-treatment-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Insomnia Treatment Market by Type
- Drugs
- Antidepressants
- Benzodiazepine
- Nonbenzodiazepine
- Melatonin Receptor Agonist
- Orexin Antagonist
- Others
- Devices
Global Insomnia Treatment Market by Sales Channels
- Prescription
- Over-the-Counter (OTC)
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Arena Pharmaceuticals, Inc.
- Boehringer Ingelheim International GmbH
- Eisai Co. Ltd.
- Electromedical Products International Inc.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Mallinckrodt LLC
- Merck & Co. Inc.
- Mylan N.V.
- Natrol, LLC
- Paratek Pharmaceuticals Inc.
- Pfizer Inc.
- Sanofi SA
- Sumitomo Dainippon Pharma Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Vanda Pharmaceuticals Inc.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global insomnia treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/insomnia-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
